Login / Signup
Anti-Lipoprotein Lipase Antibody as a Useful Marker for Plaque Vulnerability in Patients with Stable Angina.
Miyu Yoshinaga
Eika Yuasa
Tetsuro Matsuoka
Shinji Kihara
Hiroyasu Yamamoto
Published in:
Journal of atherosclerosis and thrombosis (2024)
Serum anti-LPL Ab levels can serve as a marker of plaque instability in CAD patients and can help identify higher-risk cases when combined with anti-apoB-100 Ab levels.
Keyphrases
</>
coronary artery disease
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
percutaneous coronary intervention
coronary artery
prognostic factors
climate change
atrial fibrillation
breast cancer risk